Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study
Maria Sund(Örebro University), Antonios Valachis(Örebro University Hospital), Hans Garmo(Uppsala University), Henrik Lindman(Uppsala University), Anna-Karin Wennstig(Sundsvall Municipality), Irma Fredriksson(Karolinska University Hospital), Miguel Garcia‐Argibay(Örebro University), Johan Ahlgren(Uppsala University)
Cited by 41
Related Papers
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
|The Lancet|2000|343
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [<sup>68</sup>Ga]ABY-025 Affibody PET/CT
|Theranostics|2015|269
Plasma vitamin D and mortality in older men: a community-based prospective cohort study
|American Journal of Clinical Nutrition|2010|263